Addiction to budda blues : About 2 clinical cases

TL;DR

This paper presents two clinical cases of addiction to a synthetic drug called Buddha Blue (PTC), highlighting its dangerous effects and the need for early treatment.

Contribution

The paper introduces clinical insights into PTC addiction through real-world patient cases, emphasizing its medical and psychiatric risks.

Findings

PTC addiction can cause acute delirious flush requiring long-term treatment.

PTC intoxication can lead to somatic and psychiatric symptoms like hallucinations and vomiting.

Both cases required addictological follow-up and child psychiatric therapy.

Abstract

Buddha Blue, or PTC for “Pète Ton Crâne”, is a synthetic drug particularly popular with young people. It is sold as a liquid to be inhaled in electronic cigarettes.

To discuss the clinical manifestations and psychopathology associated with PTC.

We shed light on PTC addiction through clinical vignettes of patients who were hospitalized in pediatrics at the Gonesse hospital.

We received two male patients with manifestations of PTC intoxication or withdrawal. One of the patients presented with an acute delirious flush requiring long-term treatment, while the second presented with somatic manifestations of pain and vomiting, as well as psychiatric manifestations such as hallucinations, without meeting the criteria for a psychiatric disorder. Both cases required addictological follow-up and child psychiatric therapy.

PTC addiction can lead to life-threatening complications, hence the importance of prevention and screening in order to institute early and effective treatment.

None Declared